By vanstrokepr on October 28, 2015
The VSP is now actively recruiting for DATAS-II: Dabigatran following Transient ischemic attack and minor Stroke. The trial is funded by CIHR.
For more information visit:
https://clinicaltrials.gov/ct2/show/NCT02295826
Posted in News
Since 1980, VGH & UBC Hospital Foundation has partnered with donors to provide the funds ...
The Heart and Stroke Foundation is one of Canada’s largest and most effective health charities.
A stroke is a sudden loss of brain function. It is caused by the interruption ...
Research has shown that people of South Asian descent are at greater risk of developing ...
The Heart and Stroke Foundation of Canada has translated resources to help Chinese Canadians
The 17th annual Western Stroke Conference will occur on November 28th 2015 at the Rosewood ...
VSP has secured a pilot research grant from Boehringer-Ingleheim Canada to conduct PROPHECY: prospective validation ...
The VSP is now actively recruiting for DATAS-II: Dabigatran following Transient ischemic attack and minor ...